Tema ETF Trust | | | | | | |
Tema Monopolies and Oligopolies ETF | | | | | | |
Schedule of Investments | | | | | | |
November 30, 2023 (Unaudited) | | | | | | |
| | | | | | |
Investments | | Number of Shares | | | Value | |
COMMON STOCKS - 97.7% | | | | | | |
Aerospace & Defense - 10.4% | | | | | | |
Airbus SE^ | | | 2,232 | | | $ | 330,901 | |
Safran S.A.^ | | | 1,968 | | | | 344,930 | |
| | | | | | | 675,831 | |
Capital Markets - 19.8% | | | | | | | | |
CME Group, Inc. | | | 960 | | | | 209,626 | |
Intercontinental Exchange, Inc. | | | 2,232 | | | | 254,091 | |
Moody's Corp. | | | 960 | | | | 350,362 | |
MSCI, Inc. | | | 370 | | | | 192,714 | |
S&P Global, Inc. | | | 671 | | | | 279,022 | |
| | | | | | | 1,285,815 | |
Chemicals - 3.3% | | | | | | | | |
Sherwin-Williams Co. (The) | | | 768 | | | | 214,118 | |
Commercial Services & Supplies - 3.5% | | | | | | | | |
Copart, Inc.* | | | 4,512 | | | | 226,593 | |
Construction & Engineering - 7.7% | | | | | | | | |
Ferrovial SE^ | | | 5,754 | | | | 198,919 | |
Vinci S.A.^ | | | 2,472 | | | | 302,172 | |
| | | | | | | 501,091 | |
Construction Materials - 3.0% | | | | | | | | |
Vulcan Materials Co. | | | 912 | | | | 194,767 | |
Diversified Telecommunication Services - 2.5% | | | | | | | | |
Cellnex Telecom S.A.^ (a) | | | 4,296 | | | | 163,853 | |
Financial Services - 5.0% | | | | | | | | |
Visa, Inc., Class A | | | 1,272 | | | | 326,497 | |
Ground Transportation - 8.5% | | | | | | | | |
Canadian National Railway Co. - ADR^ | | | 2,472 | | | | 286,628 | |
Canadian Pacific Kansas City Ltd. - ADR^ | | | 3,696 | | | | 266,112 | |
| | | | | | | 552,740 | |
Health Care Equipment & Supplies - 6.3% | | | | | | | | |
Alcon, Inc.^ | | | 1,608 | | | | 121,045 | |
Carl Zeiss Meditec AG^ | | | 888 | | | | 79,569 | |
Coloplast A/S, Class B^ | | | 816 | | | | 96,271 | |
IDEXX Laboratories, Inc.* | | | 240 | | | | 111,797 | |
| | | | | | | 408,682 | |
Life Sciences Tools & Services - 2.0% | | | | | | | | |
Thermo Fisher Scientific, Inc. | | | 266 | | | | 131,872 | |
Machinery - 1.9% | | | | | | | | |
Otis Worldwide Corp. | | | 1,392 | | | | 119,420 | |
Pharmaceuticals - 3.8% | | | | | | | | |
Merck & Co., Inc. | | | 1,008 | | | | 103,300 | |
Novo Nordisk A/S, Class B^ | | | 1,392 | | | | 141,361 | |
| | | | | | | 244,661 | |
Professional Services - 5.1% | | | | | | | | |
Equifax, Inc. | | | 828 | | | | 180,264 | |
RELX plc^ | | | 3,888 | | | | 149,216 | |
| | | | | | | 329,480 | |
Semiconductors & Semiconductor Equipment - 6.2% | | | | | | | | |
ASML Holding N.V.^ | | | 264 | | | | 179,027 | |
KLA Corp. | | | 121 | | | | 65,899 | |
Lam Research Corp. | | | 216 | | | | 154,639 | |
| | | | | | | 399,565 | |
Software - 6.8% | | | | | | | | |
Fair Isaac Corp.* | | | 193 | | | | 209,907 | |
Intuit, Inc. | | | 408 | | | | 233,156 | |
| | | | | | | 443,063 | |
Transportation Infrastructure - 1.9% | | | | | | | | |
Aena SME S.A.*^ (a) | | | 722 | | | | 124,132 | |
TOTAL COMMON STOCKS (Cost $5,889,724) | | | | | | | 6,342,180 | |
| | | | | | | | |
SHORT-TERMS INVESTMENTS - 2.3% | | | | | | | | |
Money Market Fund | | | | | | | | |
First American Treausry Obligations Fund - Class X, 5.277% (b) | | | 147,223 | | | | 147,223 | |
TOTAL SHORT-TERMS INVESTMENTS (Cost $147,223) | | | | | | | 147,223 | |
| | | | | | | | |
TOTAL INVESTMENTS (Cost $6,036,947) - 100.0% | | | | | | | 6,489,403 | |
OTHER ASSETS LESS LIABILITIES - 0.0% (c) | | | | | | | 639 | |
NET ASSETS - 100.0% | | | | | | $ | 6,490,042 | |
* Non-income producing security. | | | | | |
^ Foreign security. | | | | | |
(a) Securities purchased pursuant to Rule 144A of the Securities Act of 1933, as amended, and may be sold only to dealers in that program or other “qualified institutional buyers.” These securities have been deemed to be liquid by the Fund’s adviser under the supervision of the Board of Trustees. As of November 30, 2023, the value of these investments was $287,985 or 4.4% of total net assets. | |
(b) 7-day net yield. | | | | | |
(c) Represents less than 0.05%. | | | | | |
ADR - American Depositary Receipt | | | | | |
plc - Public Limited Company | | | | | |
| | | | | |
The Global Industry Classification Standard (GICS®) was developed by and/or is the exclusive property of MSCI, Inc. and Standard & Poor Financial Services LLC (“S&P”). GICS is a service mark of MSCI and S&P and has been licensed for use by U.S. Bank Global Fund Services. | |